|
Market Cap (4-Jul) $77,366,520 (1,153rd) |
Close (30-Jun) $0.025 |
Volume (30-Jun) 981,823 |
Shortsold (10-Jun) 33,792 (0.00%) (569th) |
|
52w High $0.060 |
52w Low $0.024 |
P/E - |
EPS -0.01 |
PCK released this announcement to the ASX on 20 November 2020, 15:49. The announcement is not marked as price sensitive, and is 13 page(s) in length and 365.57kb in size.
You can view all announcements from PCK and see how they appear on a price chart on the announcements page.
At the date of this announcement, PCK was 0.248% short sold according to ASIC data. It was ranked the 341st most shorted stock on the ASX. It remains ranked 569th as of the latest reported data (10 June 2025).
| Other Recent Announcements from PCK | |
|---|---|
| Ethos Laboratories Distribution Agreement | 15 June 2023, 10:52 |
| Investor Presentation Webinar | 2 May 2023, 8:31 |
| Quarterly Investor Webinar - Tuesday 2 May | 28 April 2023, 16:30 |
| Appendix 3G | 20 November 2020, 15:49 |
| PainChek receives regulatory clearance from Health Canada | 19 November 2020, 9:23 |
| PainChek to Present at NWR Virtual Conference | 3 November 2020, 8:19 |
| Quarterly Update Addendum | 3 November 2020, 8:19 |
You must be logged in to post a reply.
PainChek 